Stannous Fluoride

drug
On this page

Also known as OmnigelTin fluoride (snf2)

Summary

Stannous Fluoride (CHEMBL1909079) is a phase-3 clinical-stage small molecule (ATC A01AA04); indicated across 4 conditions including gingivitis and dental caries.

At a glance

  • Status: Max clinical phase 3 (not approved)
  • Modality: Small molecule
  • ATC class: A01AA04
  • Indications: 4 conditions
  • Clinical trials: 25

Identifiers

Drug identity and classification

FieldValue
ChEMBL IDCHEMBL1909079
NameStannous Fluoride
TypeSmall molecule
Max phase3
ATCA01AA04

Also known as: Omnigel, Stannous fluoride, Tin fluoride (snf2), Stannous Fluoride, STANNOUS FLUORIDE

Targets

Targets

No target linkage available.

Bioactivity

No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).

Target pathways

No target-pathway data for this drug (no mapped target genes).

Indications & clinical

Indications

4 indications (3 at ChEMBL trial phase 4). Phase below is the highest clinical-trial phase recorded for this drug against each disease — not the molecule’s overall approval status (that is in the Summary).

IndicationTrial phaseMONDOEFO
gingivitis4MONDO:0002508MONDO:0002508
dental caries4MONDO:0005276EFO:0003819
tooth disorder3MONDO:0006999EFO:1001216

1 further indication record had no mapped disease name (EFO/MeSH-only) or were duplicates, and are omitted.

Clinical trials

Total trials: 25.

Phase distribution

PhaseTrials
Not specified13
PHASE38
PHASE43
PHASE21

Top trials by phase / activity

NCTPhaseStatusTitle
NCT01317446PHASE4COMPLETEDEffect of Mouthrinsing on Inflammation of the Gums.
NCT02731833PHASE4COMPLETEDShort Term Clinical Study Investigating the Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal Hypersensitivity
NCT02923895PHASE4COMPLETEDTo Investigate the Efficacy of an Occluding Dentifrice in Dentinal Hypersensitivity (DH)
NCT07215767PHASE3RECRUITINGClinical Study to Investigate the Antihypersensitivity Efficacy of a Novel Dentifrice
NCT00762177PHASE3COMPLETEDInvestigate Oral Bacteria in Adult Population
NCT01592851PHASE3COMPLETEDClinical Efficacy of a Toothpaste in Providing Relief From the Pain of Dentinal Hypersensitivity
NCT01592864PHASE3COMPLETEDThe Efficacy of a Dentifrice in Providing Relief From the Pain of Dentinal Hypersensitivity
NCT01827670PHASE3COMPLETEDInvestigating the Efficacy of a Dentifrice in Providing Long Term Relief From Dentinal Hypersensitivity
NCT02832375PHASE3COMPLETEDInvestigating the Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal Hypersensitivity
NCT03072719PHASE3COMPLETEDThe Efficacy of a Dentifrice in Providing Relief From Immediate and Short Term Relief From Dentinal Hypersensitivity
NCT04123665PHASE3COMPLETEDA Phase 3 Clinical Study Investigating the Gingivitis Efficacy of a Test Dentifrice Containing Stannous Fluoride
NCT03943095PHASE2COMPLETEDStudy to Characterize the Efficacy of a Dual Active Dentifrice for the Relief of Dentin Hypersensitivity
NCT02750943Not specifiedCOMPLETEDPotential of Stannous Fluoride Toothpaste to Reduce Gum Disease
NCT02752958Not specifiedCOMPLETEDImpact of Long Term Management of Dentine Hypersensitivity (DH) With a Daily Use Anti-sensitivity Toothpaste on the Quality of Life Related to Oral Health
NCT02768194Not specifiedCOMPLETEDDentine Tubule Occlusion Assessment in a Modified in Situ Model
NCT02841839Not specifiedCOMPLETEDA Study to Evaluate Sampling Methods for Subgingival Plaque
NCT02861664Not specifiedCOMPLETEDAssessment of the Efficacy of an Experimental Occlusion Technology Dentifrice in Dentinal Hypersensitivity
NCT02924350Not specifiedCOMPLETEDThe Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal Hypersensitivity (DH)
NCT02937636Not specifiedCOMPLETEDTo Investigate the Gingivitis Efficacy of a Stannous Fluoride Dentifrice in a Chinese Population
NCT03160703Not specifiedCOMPLETEDStudy to Investigate the Stain Control of Two Stannous Fluoride Dentifrices
NCT03296657Not specifiedCOMPLETEDAnalysis of Stannous Fluoride in GCF and Subgingival Plaque
NCT05326373Not specifiedCOMPLETEDStannous Fluoride and Gingivitis
NCT05483062Not specifiedCOMPLETEDEffectiveness of Toothpaste Containing the Active Ingredient of Galla Chinensis Extract on Treating Dentin Hypersensitivity
NCT06045026Not specifiedCOMPLETEDA Real-World Evidence Study Evaluating Oral Health Related Quality Of Life With Use Of A Stannous Fluoride Anti-Sensitivity Toothpaste For Dentin Hypersensitivity Management
NCT06197555Not specifiedCOMPLETEDComparision of the Clinical Efficacy of Different Desensitizing Toothpastes

Clinical evidence (CIViC)

No CIViC predictive evidence (expected for non-precision-medicine drugs).

Pharmacology

Pharmacogenomics

No PharmGKB pharmacogenomic data curated for this drug.

No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).